Phase 1 biotech developing novel molecules to treat solid tumors.
Industry: Health Care
Latest Trade: $0.88 -0.06 (-6.5%)
First Day Return: 0.0%
Return from IPO: -94.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/01/2021 |
Offer Price | $16.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 7.4 |
Deal Size ($mm) | $118 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/21/2021 |
Offer Price | $16.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 7.4 |
Deal Size ($mm) | $118 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2015 |
Employees at IPO | 64 |
Website www.xiliotx.com |